Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks
Diabetes, Obesity and Metabolism · 2025
DOI: 10.1111/dom.16236 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Xiao-Yue Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Obesity. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: Laboratory for Clinical Medicine, Capital Medical University, National Key Research and Development Program, National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases: Comprehensive Treatment and Management of Critically Ill El….
Abstract (Originalsprache)
Aims
Obesity is a global public health challenge, and the traditional WHO‐proposed diagnostic criteria based on body mass index (BMI) often fail to fully assess related health risks. The European Association for the Study of Obesity (EASO) has proposed new criteria that combine BMI, waist‐to‐height ratio (WtHR) and complications to more accurately evaluate obesity‐related health risks. Materials and Methods This study utilized data from the National Health and Nutrition Examination Survey database, covering the years 1999–2018. The study validated the new EASO criteria for diagnosing obesity, defined as BMI ≥25 kg/m 2 , WtHR ≥0.5 and the presence of 12 obesity‐related complications. The associations between obesity and mortality were assessed using Kaplan–Meier survival curves and Cox proportional hazards regression analyses. Mediation analysis was conducted to explore potential mechanisms by which obesity impacts patient prognosis.
Results
A total of 39 066 participants were included, with a mean age of 43.6 years; 51.3% were male. Over a median follow‐up period of 141 months, 3708 deaths were recorded. The prevalence of obesity was 63.04% according to the new EASO criteria. The obesity rate based on BMI ≥30 is only 35.55%. The EASO criteria achieved a C‐index of 0.5549, which surpasses the predictive accuracy of the traditional BMI ≥30 kg/m 2 criterion, with a C‐index of 0.5265. Cox regression analysis indicated that when using the traditional BMI ≥30 criterion to diagnose obesity, it was associated with all‐cause mortality and cardiovascular disease (CVD)‐related mortality, but it did not predict cancer‐related mortality. Obesity diagnosed by EASO criteria was significantly associated with an increased risk of all‐cause mortality (hazard ratio [HR] and 95% confidence interval [CI]: 1.13 [1.02, 1.24]), CVD mortality (HR and 95% CI: 1.48 [1.20, 1.83]) and cancer mortality (HR and 95% CI: 1.26 [1.03, 1.54]). When using simplified BMI ≥25 kg/m 2 , WtHR ≥0.5 and any of the top five complications (diabetes mellitus, hypertension, CVD, metabolic syndrome and ageing) as diagnostic criteria, which had the highest C‐index (0.612), obesity remained an independent prognostic factor for poor overall survival (HR and 95% CI for all‐cause mortality: 1.41 [1.26, 1.58], HR for CVD mortality: 2.08 [1.61, 2.68] and HR for cancer mortality: 1.32 [1.06, 1.65]).
Conclusions
This study confirms the prognostic value of the new obesity diagnostic criteria proposed by EASO, suggesting that these criteria offer a more accurate assessment of obesity‐related health risks.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Department of Clinical Nutrition, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
- National Clinical Research Center for Geriatric Diseases, Xuanwu Hospital, Capital Medical University, Beijing, China.
- Key Laboratory of Cancer FSMP for State Market Regulation, Beijing, China.
- Beijing International Science and Technology Cooperation Base for Cancer Metabolism and Nutrition, Beijing, China.
ORCID-Profile: Han-Ping Shi
Förderung
- Laboratory for Clinical Medicine, Capital Medical University
- National Key Research and Development Program
- National Multidisciplinary Cooperative Diagnosis and Treatment Capacity Project for Major Diseases: Comprehensive Treatment and Management of Critically Ill El…
- National Key Research and Development Program of China
Zitieren
APA
Liu, X. Y., Ge, S. Y., Liu, C. A., Yin, B., Bu, Z. T., Zheng, X., Chen, Y., Li, X. R., & Shi, H. P. (2025). Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16236
Vancouver
Liu XY, Ge SY, Liu CA, Yin B, Bu ZT, Zheng X, et al. Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16236
BibTeX
@article{Liu2025,
author = {Liu, Xiao-Yue and Ge, San-Yu and Liu, Chen-An and Yin, Bing and Bu, Zhao-Ting and Zheng, Xin and Chen, Yue and Li, Xiang-Rui and Shi, Han-Ping},
title = {Validation of the 2024 European Association for the Study of Obesity diagnostic criteria: A comprehensive assessment of obesity‐related mortality risks},
journal = {Diabetes, Obesity and Metabolism},
year = {2025},
doi = {10.1111/dom.16236}
}
EUVIMED